Ffatri a gweithgynhyrchwyr Epalrestat Tsieina | Tecsun

Epalrestat

Disgrifiad Byr:

 Epalrestat  CAS No.: 82159-09-9 Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function. Epalrestat is used to prevent, ameliorate, and treat peripheral neuropathy (numbnes...


Manylion y Cynnyrch

Tagiau Cynnyrch

 Rhif  CAS82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Defnyddir epalrestat i atal, lliniaru, a thrin niwroopathi ymylol (fferdod, poen), paresthesia dirgrynol, ac annormaledd cardiaidd sy'n gysylltiedig â diabetes. MANYLEB
P Enw'r roduct Epalrestat
CAS 82159-09-9
MF: C15H13NO3S2
MW: 319.4
 

 

 

 
 
 


  • Blaenorol:
  • Nesaf:

  • Ysgrifennwch eich neges yma a'i hanfon atom ni